BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2297916)

  • 1. Evaluation of sialic acid concentrations in serum for the diagnosis and staging of breast cancer.
    Riley WM; Tautu C; Verazin G; Gregory J; Josiah S; Prorok JJ; Alhadeff JA
    Clin Chem; 1990 Jan; 36(1):161-2. PubMed ID: 2297916
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Cancer Lett; 1990 Jun; 51(3):203-8. PubMed ID: 2161706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid and CEA concentrations in human breast cancer.
    Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
    Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer.
    Kiricuta I; Bojan O; Comes R; Cristian R
    Arch Geschwulstforsch; 1979; 49(2):106-12. PubMed ID: 475547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive history and prognosis in patients with operable breast cancer.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Cancer; 1995 Aug; 76(3):531-3. PubMed ID: 8625140
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of sialic acid and alkaline DNase in breast cancer.
    Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
    Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
    Romppanen J; Eskelinen M; Tikanoja S; Mononen I
    Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
    O'Kennedy R; Berns G; Moran E; Smyth H; Carroll K; Thornes RD; O'Brien A; Fennelly J; Butler M
    Cancer Lett; 1991 Jun; 58(1-2):91-100. PubMed ID: 2049789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total sialic acid as a tumor marker for oral cancer.
    Xing RD; Wang ZS; Li CQ; Tang QY; Jiang CB; Zhang YZ
    Int J Biol Markers; 1994; 9(4):239-42. PubMed ID: 7836802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipid-bound sialic acid as a marker in breast cancer.
    Dnistrian AM; Schwartz MK; Katopodis N; Fracchia AA; Stock CC
    Cancer; 1982 Nov; 50(9):1815-9. PubMed ID: 7116306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variations in serum sialic acid in patients operated on for colonic cancer].
    Creperio G; Familiari G; Ranzini C
    Minerva Med; 1985 Oct; 76(40):1851-3. PubMed ID: 4058782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.